Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Agile Sciences
company
About
Agile Sciences is a biotechnology company that provides commercial solutions to the biopharma industry.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $180K
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2007
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Agile Sciences is a biotechnology company that provides commercial solutions to the biopharma industry. The company is driven by its mission is to provide commercial solutions to those industries plagued by antibiotic resistance and biofilms. Internal R&D efforts at the Company are focused on pharmaceutical applications of the technology.It was founded in 2007 and headquartered in Raleigh, North Carolina.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$180K
Agile Sciences has raised a total of
$180K
in funding over 2 rounds. Their latest funding was raised on
Jun 12, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 12, 2012 | Grant | $180K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Agile Sciences is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
